Wells Fargo & Company Cuts Crescent Capital BDC (NASDAQ:CCAP) Price Target to $16.00

Crescent Capital BDC (NASDAQ:CCAP) had its target price cut by stock analysts at Wells Fargo & Company from $18.00 to $16.00 in a research note issued on Monday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s target price suggests a potential downside of 1.17% from the stock’s current price.

Separately, Keefe, Bruyette & Woods decreased their target price on shares of Crescent Capital BDC from $20.00 to $18.50 and set an “outperform” rating on the stock in a research report on Tuesday, April 8th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $18.50.

Crescent Capital BDC Trading Down 0.3 %

Shares of CCAP stock opened at $16.19 on Monday. The business has a 50-day moving average price of $16.65 and a two-hundred day moving average price of $18.29. Crescent Capital BDC has a 12-month low of $13.54 and a 12-month high of $20.19. The company has a quick ratio of 1.26, a current ratio of 1.32 and a debt-to-equity ratio of 1.18. The firm has a market cap of $600.03 million, a P/E ratio of 8.14 and a beta of 0.56.

Crescent Capital BDC (NASDAQ:CCAP) last issued its quarterly earnings results on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01). The business had revenue of $46.40 million for the quarter, compared to the consensus estimate of $47.27 million. Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. Equities analysts anticipate that Crescent Capital BDC will post 2.09 EPS for the current fiscal year.

Institutional Investors Weigh In On Crescent Capital BDC

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CCAP. Montag A & Associates Inc. bought a new stake in Crescent Capital BDC in the 4th quarter worth $35,000. C M Bidwell & Associates Ltd. purchased a new stake in shares of Crescent Capital BDC during the fourth quarter worth about $39,000. Aquatic Capital Management LLC bought a new stake in shares of Crescent Capital BDC in the fourth quarter worth about $129,000. Generation Capital Management LLC purchased a new position in Crescent Capital BDC during the 4th quarter valued at about $192,000. Finally, First Affirmative Financial Network bought a new position in Crescent Capital BDC during the 1st quarter valued at approximately $199,000. 49.46% of the stock is currently owned by institutional investors.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.